Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.3100
+0.0140 (4.73%)
Last updated: Oct 7, 2026, 8:16 PM CET

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
333614171011
Market Cap Growth
83.69%148.17%-15.29%61.96%-7.18%-45.46%
Enterprise Value
333515181212
Last Close Price
0.310.340.140.190.130.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
1926.23961.85145.04152.12100.50356.91
PB Ratio
93.76173.7012.85-40.73-13.42-24.67
P/TBV Ratio
93.76173.7012.85---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-952.24154.52161.35110.73393.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
2.234.290.64-2.54-1.44-3.09
Net Debt / Equity Ratio
0.851.24-0.78-2.28-1.37-2.49
Net Debt / EBITDA Ratio
-0.28-0.240.67-0.82-0.86-1.24
Net Debt / FCF Ratio
-0.45-0.371.24-1.41-1.72-1.25
Asset Turnover
0.010.020.070.180.140.04
Quick Ratio
1.260.972.140.160.060.31
Current Ratio
1.290.992.140.160.080.33
Return on Equity (ROE)
-149.87%-142.59%-340.70%---
Return on Assets (ROA)
-45.63%-43.06%-60.59%-117.29%-104.38%-66.20%
Return on Capital Employed (ROCE)
-117.50%-225.70%-107.60%1099.30%197.40%4328.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-2.66%-2.57%-8.62%-5.75%-11.94%-9.27%
FCF Yield
-1.99%-1.90%-4.90%-3.98%-5.96%-8.06%
Buyback Yield / Dilution
-11.57%-15.58%-6.67%-2.97%-6.22%-6.31%